Skip to content

MAZE MAZE Restricted Cash

Restricted Cash at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
$905K0.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.23M+4,203%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$968K+7.4%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$207K
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.34M-37.0%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's restricted cash?
MAZE (MAZE) reported restricted cash of $1.09M in Q1 2026.
How has MAZE's restricted cash changed year-over-year?
MAZE's restricted cash decreased by 0.1% year-over-year, from $1.09M to $1.09M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.